Evidence map›Paper›PMID 35096624›Full record

ReviewFrontiers in oncology2021

The Emerging Role of Tissue-Resident Memory CD8

Xinyu Mei, Huan Li, Xinpeng Zhou, Min Cheng, Kele Cui

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Immune biomarkers for head and neck cancer.Cancer immunology, immunotherapy : CII · 2025
    Review
  3. CD49aBritish journal of cancer · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Cytolytic CD4Frontiers in immunology · 2022
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Xinyu MeiDepartment of Thoracic Surgery, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Huan LiDepartment of Thoracic Surgery, Anhui Provincial Hospital Affiliated With Anhui Medical University, Hefei, China.
Xinpeng ZhouDepartment of Thoracic Surgery, Anhui Provincial Hospital, Wannan Medical College, Hefei, China.
Min ChengDepartment of Geriatrics, Gerontology Institute of Anhui Province, The First Affiliated Hospital of University of Science and Technology of China (USTC), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Kele CuiAnhui Provincial Key Laboratory of Tumor Immunotherapy and Nutrition Therapy, Hefei, China.
University of Science and Technology of China · CNAnhui Medical University · CNWannan Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant digestive tract tumors are a great threat to human public health. In addition to surgery, immunotherapy brings hope for the treatment of these tumors. Tissue-resident memory CD8

Indexed as

antitumor effectsCD8+ Trm cellscharacteristicsdigestive tract tumorsimmunotherapy

Identifiers

PMID35096624
PMCPMC8795735
OpenAlexW4206689336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.